Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Biolingus (Cayman) Limited To Start Trading Tomorrow

BIOLINGUS (CAYMAN) LIMITED (NASDAQ:SUBL) IPO will take place January, 31 on the NASDAQ exchange under the ticker SUBL.…
byBenzinga Insights
January 30, 2024
1 minute read
Total
0
Shares
0
0
0
0
0
0

BIOLINGUS (CAYMAN) LIMITED (NASDAQ:SUBL) IPO will take place January, 31 on the NASDAQ exchange under the ticker SUBL.

The company is offering shares at an expected price between $15.00 and $16.00 per share with an insider lock-up period of 180 days ending on July 29, 2024.

See also: Benzinga IPO Calendar

About BIOLINGUS (CAYMAN) LIMITED

BIOLINGUS (CAYMAN) LIMITED is a Cayman Islands-incorporated exempt holding company whose main business operations are conducted through our subsidiaries in Switzerland and to a lesser extent, Hong Kong and the People’s Republic of China.

See also: Benzinga’s Most Shorted Stocks

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

HeartCore Signs 14th Go IPO Contract; HeartCore Expects To Generate From Koei Shoji An Aggregate Of $500,000 In Initial Fees, Also Received A Warrant To Acquire 3% Of Koei Shoji’s Common Stock, On A Fully Diluted Basis

By Benzinga Newsdesk
April 15, 8:32 AM
HeartCore Enterprises, Inc. (NASDAQ:HTCR) ("HeartCore" or the "Company"), a leading enterprise software and consulting services company based in Tokyo, announced that it has signed an agreement ("Consulting Agreement")

HTCR